Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Ulcerative colitis and Crohn's disease, commonly known as inflammatory bowel disease (IBD), draw attention from specialists of various disorders, including gastroenterology, psychiatry, and radiology. The involvement of a cortical influence in the brain-gut axis as well as the interaction of the hypothalamic-pituitary-adrenal axis and the peripheral nervous system provide an initial explanation of the psychological symptoms associated with IBD. The involvement of structures the limbic system, such as the anterior cingulate cortex, the prefrontal cortex, and the amygdala, paves the way for the discovery of the mechanisms underlying depression depression, anxiety, alexithymia, personality traits, and other psychological impairments following the onset of IBD. Psychiatric therapy in IBD patients is almost as important as the gastroenterological approach and consists of pharmacological treatment and psychotherapy. Neither of the available psychiatric treatment methods is considered the golden standard because both methods have side effects, and psychotropic medication can provoke the worsening of IBD symptoms. Thus, both approaches must be applied with awareness of the possibility of side effects. We suggest that psychiatrists and gastroenterologists work together to reach a consensus on IBD therapy to ensure success and to reduce side effects and relapse to the lowest possible rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Bagby, R. M., Parker, J. D. A., & Taylor, G. J. (1994) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(94)90005-1 · Cited by 5,293
The Current State of Cognitive Therapy: A 40-Year Retrospective
Beck, A. T. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.9.953 · Cited by 816
Clinical, biological, and endoscopic picture of attacks of Crohn's disease
Modigliani, R., Mary, J.-Y., Simon, J.-F., Cortot, A., Soule, J.-C., Gendre, J.-P., & Rene, E. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90002-i · Cited by 699
Osborn, R. L., Demoncada, A. C., & Feuerstein, M. (2006) · The International Journal of Psychiatry in Medicine · doi:10.2190/eufn-rv1k-y3tr-fk0l · Cited by 621
Depression and anxiety in inflammatory bowel disease: A review of comorbidity and management
Graff, L. A., Walker, J. R., & Bernstein, C. N. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20873 · Cited by 586
Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Tillinger, W., Gangl, A., & Moser, G. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000106907.24881.f2 · Cited by 532
Stress and Exacerbation in Ulcerative Colitis: A Prospective Study of Patients Enrolled in Remission
Levenstein, S., Prantera, C., Varvo, V., Scribano, M. L., Andreoli, A., Luzi, C., Arcà, M., Berto, E., Milite, G., & Marcheggiano, A. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02012.x · Cited by 451
Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389
Dalton, S. O., Johansen, C., Mellemkjær, L., Sørensen, H. T., Nørgård, B., & Olsen, J. H. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.59 · Cited by 389
Oral budesonide is as effective as oral prednisolone in active Crohn’s disease
Campieri, M., Ferguson, A., Doe, W., Persson, T., Nilsson, L.-G., & the Global Budesonide Study Group (1997) · Gut · doi:10.1136/gut.41.2.209 · Cited by 324
Predicting relapse in Crohn’s disease: a biopsychosocial model
Bitton, A., Dobkin, P. L., Edwardes, M. D., Sewitch, M. J., Meddings, J. B., Rawal, S., Cohen, A., Vermeire, S., Dufresne, L., Franchimont, D., et al. (2008) · Gut · doi:10.1136/gut.2007.134817 · Cited by 254
Psychological issues in inflammatory bowel disease: an overview
Sajadinejad, M. S., Asgari, K., Molavi, H., Kalantari, M., & Adibi, P. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/106502 · Cited by 242
Psychosocial determinants of relapse in ulcerative colitis: A longitudinal study
Bitton, A., Sewitch, M. J., Peppercorn, M. A., de B Edwardes, M. D., Shah, S., Ransil, B., & Locke, S. E. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07717.x · Cited by 226
Brown, C., Battista, D. R., Bruehlman, R., Sereika, S. S., Thase, M. E., & Dunbar-Jacob, J. (2005) · Medical Care · doi:10.1097/01.mlr.0000185733.30697.f6 · Cited by 204
Psychological interventions for treatment of inflammatory bowel disease
Timmer, A., Preiss, J. C., Motschall, E., Rücker, G., Jantschek, G., & Moser, G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006913.pub2 · Cited by 187
SZIGETHY, E., KENNEY, E., CARPENTER, J., HARDY, D. M., FAIRCLOUGH, D., BOUSVAROS, A., KELJO, D., WEISZ, J., BEARDSLEE, W. R., NOLL, R., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180f6341f · Cited by 183
Type D personality among noncardiovascular patient populations: a systematic review
Mols, F., & Denollet, J. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2009.09.010 · Cited by 154
Gartlehner, G., Thieda, P., Hansen, R. A., Gaynes, B. N., DeVeaugh-Geiss, A., Krebs, E. E., & Lohr, K. N. (2008) · Drug Safety · doi:10.2165/00002018-200831100-00004 · Cited by 150
Bennebroek Evertsz', F., Thijssens, N. A. M., Stokkers, P. C. F., Grootenhuis, M. A., Bockting, C. L. H., Nieuwkerk, P. T., & Sprangers, M. A. G. (2012) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2011.07.006 · Cited by 131
Evaluation of a psychological treatment for inflammatory bowel disease
Schwarz, S. P., & Blanchard, E. B. (1991) · Behaviour Research and Therapy · doi:10.1016/0005-7967(91)90045-5 · Cited by 131
Suffering in silence: reasons for not disclosing depression in primary care
Bell, R. A., Franks, P., Duberstein, P. R., Epstein, R. M., Feldman, M. D., Garcia, E. F. Y., & Kravitz, R. L. (2011) · The Annals of Family Medicine · doi:10.1370/afm.1277 · Cited by 121
Larsson, K., Lööf, L., Rönnblom, A., & Nordin, K. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.10.007 · Cited by 115
Gastro‐intestinal haemorrhage risks of selective serotonin receptor antagonist therapy: a new look
Opatrny, L., Delaney, J. A. ‘., & Suissa, S. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03154.x · Cited by 95
Langhorst, J., Mueller, T., Luedtke, R., Franken, U., Paul, A., Michalsen, A., Schedlowski, M., Dobos, G. J., & Elsenbruch, S. (2007) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520601101682 · Cited by 94
SZIGETHY, E., WHITTON, S. W., LEVY-WARREN, A., DeMaso, D. R., WEISZ, J., & BEARDSLEE, W. R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000142284.10574.1f · Cited by 92
Moreno-Jiménez, B., López Blanco, B., Rodríguez-Muñoz, A., & Garrosa Hernández, E. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.07.026 · Cited by 89
Which patients with IBD need psychological interventions? A controlled study
Miehsler, W., Weichselberger, M., Öfferlbauer-Ernst, A., Dejaco, C., Reinisch, W., Vogelsang, H., Machold, K., Stamm, T., Gangl, A., & Moser, G. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20462 · Cited by 82
Kast, R. E. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(03)00093-8 · Cited by 62
Remission of Crohn's disease on bupropion
Kast, R. E., & Altschuler, E. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.29467 · Cited by 58
Cognitive functioning and depressive symptoms in adolescents with inflammatory bowel disease
Castaneda, A. E. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i10.1611 · Cited by 48
Väistö, T., Aronen, E. T., Simola, P., Ashorn, M., & Kolho, K.-L. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21002 · Cited by 41
Mikocka-Walus, A. A., Gordon, A. L., Stewart, B. J., & Andrews, J. M. (2012) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.06.006 · Cited by 34
Case study: Longitudinal treatment of adolescents with depression and inflammatory bowel disease
SZIGETHY, E., CARPENTER, J., BAUM, E., KENNEY, E., BAPTISTA-NETO, L., BEARDSLEE, W. R., & DeMASO, D. R. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000198591.45949.a4 · Cited by 33
Evertsz’, F. B., Bockting, C. L., Stokkers, P. C., Hinnen, C., Sanderman, R., & Sprangers, M. A. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-227 · Cited by 30
Cited by
Kim, Y.-K., & Shin, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915141036 · Cited by 271
Macedo, D., Filho, A. J. M. C., Soares de Sousa, C. N., Quevedo, J., Barichello, T., Júnior, H. V. N., & Freitas de Lucena, D. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.012 · Cited by 261
Emge, J. R., Huynh, K., Miller, E. N., Kaur, M., Reardon, C., Barrett, K. E., & Gareau, M. G. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00086.2016 · Cited by 152
Szigethy, E. M., Allen, J. I., Reiss, M., Cohen, W., Perera, L. P., Brillstein, L., Cross, R. K., Schwartz, D. A., Kosinski, L. R., Colton, J. B., et al. (2017) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2017.02.037 · Cited by 107
From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
Bajic, J. E., Johnston, I. N., Howarth, G. S., & Hutchinson, M. R. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00104 · Cited by 100
Metadata
- Authors
- Filipovic, B. R.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2014
- Volume
- 20
- Issue
- 13
- Pages
- 3552
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2022119717
- Cited by
- 96
- References
- 35
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.